Valenti V, Hernandez-Lizoain J L, Baixauli J, Pastor C, Martinez-Regueira F, Beunza J J, Aristu J J, Alvarez Cienfuegos J
Department of General Surgery, Clinica Universitaria de Navarra, University of Navarra, Avda Pio XII, 36., 31080, Pamplona, Spain.
Langenbecks Arch Surg. 2009 Jan;394(1):55-63. doi: 10.1007/s00423-008-0314-6. Epub 2008 Mar 5.
The Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM) and later modifications (P-POSSUM y CR-POSSUM) have been used to predict morbidity and mortality rates among patients with rectal cancer undergoing surgery. These calculations need some adjustment, however. The aim of this study was to assess the applicability of POSSUM to a group of patients with rectal cancer undergoing surgery, analysing surgical morbidity by means of several variables.
between January 1995 and December 2004, 273 consecutive patients underwent surgery for rectal cancer. Information was gathered about the patients, tumour and therapy. To assess the prediction capacity of POSSUM, subgroups for analysis were created according to variables related to operative morbidity and mortality.
The global morbidity rate was 23.6% (31.2% predicted by POSSUM). The mortality rate was 0.7% (6.64, 1.95 and 2.08 predicted by POSSUM, P-POSSUM and CR-POSSUM respectively). POSSUM predictions may be more accurate for patients younger than 51 years, older than 70 years, with low anaesthetic risk (ASA I/II), DUKES stage C and D, surgery duration of less than 180 minutes and for those receiving neoadjuvant therapy.
POSSUM is a good instrument to make results between different institutions and publication comparable. We found prediction errors for some variables related to morbidity. Modifications of surgical variables and specifications for neoadjuvant therapy as well as physiological variables including life style may improve future prediction of surgical risk. More research is needed to identify further potential risk factors for surgical complications.
用于计算死亡率和发病率的生理学和手术严重程度评分系统(POSSUM)及其后续改良版本(P-POSSUM和CR-POSSUM)已被用于预测接受手术的直肠癌患者的发病率和死亡率。然而,这些计算需要一些调整。本研究的目的是评估POSSUM在一组接受手术的直肠癌患者中的适用性,并通过多个变量分析手术发病率。
1995年1月至2004年12月期间,273例连续的患者接受了直肠癌手术。收集了有关患者、肿瘤和治疗的信息。为评估POSSUM的预测能力,根据与手术发病率和死亡率相关的变量创建了分析亚组。
总体发病率为23.6%(POSSUM预测为31.2%)。死亡率为0.7%(POSSUM、P-POSSUM和CR-POSSUM分别预测为6.64、1.95和2.08)。对于年龄小于51岁、大于70岁、麻醉风险低(ASA I/II)、DUKES分期C和D、手术时间少于180分钟以及接受新辅助治疗的患者,POSSUM的预测可能更准确。
POSSUM是使不同机构间结果和出版物具有可比性的良好工具。我们发现一些与发病率相关的变量存在预测误差。手术变量的修改、新辅助治疗的规范以及包括生活方式在内的生理变量可能会改善未来手术风险的预测。需要更多研究来确定手术并发症的进一步潜在风险因素。